Reports

Diagnosed Type 1 Diabetes Cases to Reach 3.166 Million by 2033: Report

The prevalence of diagnosed type 1 diabetes (T1D) cases is set to grow steadily in seven major markets (7MM), increasing at an annual rate of 0.5%.

• By Newsdesk
• New Delhi
• Nov 19, 2024

Reports

The prevalence of diagnosed type 1 diabetes (T1D) cases is set to grow steadily in seven major markets (7MM), increasing at an annual rate of 0.5%. This rise will bring the number of cases from approximately 3.01 million in 2023 to 3.166 million by 2033, according to a recent analysis by GlobalData.  

The report, titled Type 1 Diabetes: Epidemiology Forecast to 2033, attributes this growth to advancements in medical treatments that have significantly improved life expectancy for individuals with T1D, alongside broader demographic shifts in these markets.  

In 2023, the United States recorded the highest prevalence of diagnosed T1D cases, with 1.77 million individuals affected. In contrast, Japan reported the lowest number, with just 120,000 cases.  

Commenting on the findings, Alia Rafiq, an epidemiologist at GlobalData, highlighted the remarkable progress in managing T1D over the years. "Patients now have access to improved interventions, such as insulin pumps, which help reduce life-threatening complications like diabetic ketoacidosis. This progress enables individuals with T1D to live longer and, in turn, pass on associated genetic factors to future generations, contributing to the accumulation of these genes in the population," she explained.  

The study also uncovered notable gender differences in T1D prevalence. In 2023, men accounted for slightly more than half of the diagnosed cases across the 7MM. Japan, however, stood out as the only market where women constituted the majority, representing 55% of the diagnosed T1D cases in the country.  

These findings underscore the ongoing need for advancements in treatment and management strategies to support the growing number of individuals living with T1D worldwide.